Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines
Samyang Biopharm announced on the 20th that nonclinical study results for its proprietary gene delivery platform, "NanoReady," designed for...
Search results for "lipid nanoparticles"
GC Biopharma Develops Advanced Platform to Track mRNA Vaccine Degradation
GC Biopharma has developed a technology platform capable of precisely analyzing how mRNA vaccines degrade when exposed to temperature fluctuations,...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...
Astonishing Changes After Reviving Aged Immune Cells Using the Liver...
Just as skin wrinkles and the back begins to stoop, the cells inside our bodies also age.
1